In a filing, DexCom Inc. revealed its SVP Corporate Strategy-Develop Dolan Matthew Vincent unloaded Company’s shares for reported $5730.0 on Sep 01. In the deal valued at $102.32 per share,56 shares were sold. As a result of this transaction, Dolan Matthew Vincent now holds 33,569 shares worth roughly $ 3.42 million.
Then, Pacelli Steven Robert sold 411 shares, generating $43,989 in total proceeds. Upon selling the shares at $107.03, the EVP Managing Director Dexcom V now owns 126,008 shares.
Before that, Sylvain Jereme M sold 1,844 shares. DexCom Inc. shares valued at $192,477 were divested by the EVP Chief Financial Officer at a price of $104.38 per share. As a result of the transaction, Sylvain Jereme M now holds 72,867 shares, worth roughly $7.42 million.
PT values the company’s stock at a premium of 22.22 to its Friday closing price.
Price Performance Review of DXCM
On Friday, DexCom Inc. [NASDAQ:DXCM] saw its stock jump 0.91% to $101.89. On the same session, the stock had its day’s lowest price of $100.51, but rose to a high of $102.695. Over the last five days, the stock has gained 1.13%. DexCom Inc. shares have fallen nearly -10.02% since the year began. Nevertheless, the stocks have risen 23.94% over the past one year. While a 52-week high of $139.55 was reached on 07/28/23, a 52-week low of $78.94 was recorded on 08/29/23. SMA at 50 days reached $120.27, while 200 days put it at $116.83. A total of 2.52 million shares were traded, compared to the trading of 3.71 million shares in the previous session.
Levels Of Support And Resistance For DXCM Stock
The 24-hour chart illustrates a support level at 100.71, which if violated will result in even more drops to 99.51. On the upside, there is a resistance level at 102.89. A further resistance level may holdings at 103.88. The Relative Strength Index (RSI) on the 14-day chart is 35.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.44, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 79.85%. Stochastics %K at 21.21% indicates the stock is a holding.
How much short interest is there in DexCom Inc.?
A steep rise in short interest was recorded in DexCom Inc. stocks on Aug 14, 2023, growing by 4.4 million shares to a total of 16.78 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 12.38 million shares. There was a rise of 26.22%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.90% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.75.
DexCom Inc. [DXCM] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 42,669,683 shares, or roughly 11.00% of the outstanding DXCM shares. In other words, the investor’s shares have risen by 204,006 from its previous 13-F filing of 42465677.0. Additionally, BlackRock Fund Advisors increased 2.06% of its stake after which the total value it holdings stand at $2,682,290,361, while Baillie Gifford & Co. reduced -2.53% of its stake to hold $2.08 billion in the firm. Over the last quarter, SSgA Funds Management, Inc. purchased 399,376 shares of DexCom Inc., while Sands Capital Management LLC bought -635,841 shares. At present, JPMorgan Investment Management, I is holding 9,965,550 shares valued at $1.24 billion. Fidelity Management & Research Co owned 9,209,515 shares of the company at the time of its most recent 13F filing, worth $1.15 billion.
According to FactSet, DexCom Inc.’s share price will average $149.79 in the next year, based on opinions of analysts polled by the firm. This is up nearly 48.54 percent from its previous closing price of $100.98. Analysts expect DexCom Inc. stock to reach the higher price of $175.00, while the lowest price estimate is $130.00. However, 23 analysts have rated DXCM stock as a Buy in their predictions for 2023.